New developments in treatment of migraine
Developments in understanding migraine pathogenesis and, in particular, the role of the neuropeptide, calcitonin gene-related peptide (CGRP), have led to breakthroughs which will revolutionise treatment, especially chronic migraine (defined conventionally as over 15 headache days a month). Read More...